Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Butylphthalide - CSPC Ouyi Pharmaceutical

Next Previous
X
Search
Drug Profile

Butylphthalide - CSPC Ouyi Pharmaceutical

Alternative Names: Dl-3-butylphthalide; En Bi Pu; L-butylphthalide; NBP injection; NBP soft capsule; rac-3-butyl-2-benzofuran-1(3H)-one

Latest Information Update: 01 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CSPC Ouyi Pharmaceutical
  • Class Antidementias; Benzofurans; Ketones; Phytotherapies; Small molecules; Vascular disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Stroke
  • Phase III Vascular dementia
  • Preclinical Peripheral nervous system diseases

Most Recent Events

  • 01 Nov 2023 Preclinical trials in Peripheral nervous system diseases in China (PO) (CSPC Pharmaceutical pipeline, November 2023)
  • 21 Jun 2023 Conjupro Biotherapeutics withdraws a phase II trial prior to enrolment in Peripheral nervous system disease (Prevention) (PO, Capsule) due to the reason that further preclinical development activities required to proceed (NCT04675450)
  • 21 Sep 2022 Butylphthalide is still in phase-III clinical trials for Vascular dementia (In adults, In the elderly) in China (PO) (NCT03804229)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top